I. Tugal-tutkun, S. Onal, and R. Altan-yaycioglu, Uveitis in Behcet disease: an analysis of 880 patients, Am J Ophthalmol, vol.138, issue.3, pp.373-380, 2004.

F. Davatchi, F. Shahram, and C. Chams-davatchi, Behcet's disease in Iran: analysis of 6500 cases, Int J Rheum Dis, vol.13, issue.4, pp.367-373, 2010.

M. El-belhadji, M. Hamdani, and N. Laouissi,

, J Fr Ophtalmol, vol.20, issue.8, pp.592-598, 1997.

G. Hatemi, A. Silman, and D. Bang, Management of Behcet disease: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for the management of Behcet disease, Ann Rheum Dis, vol.68, issue.10, pp.1528-1534, 2009.

I. Kotter, I. Gunaydin, and M. Zierhut, The use of interferon alpha in Behcet disease: review of the literature, Semin Arthritis Rheum, vol.33, issue.5, pp.320-335, 2004.

D. A. Jabs, R. B. Nussenblatt, and J. T. Rosenbaum, Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop, Am J Ophthalmol, vol.140, issue.3, pp.509-516, 2005.

J. Gueudry, B. Wechsler, and C. Terrada, Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behcet disease, Am J Ophthalmol, vol.146, issue.6, pp.837-844, 2008.

I. Tugal-tutkun, E. Guney-tefekli, and M. Urgancioglu, Results of interferon-alfa therapy in patients with Behcet uveitis, Graefes Arch Clin Exp Ophthalmol, vol.244, issue.12, pp.1692-1695, 2006.

L. Krause, A. Altenburg, and U. Pleyer, Longterm visual prognosis of patients with ocular Adamantiades-Behçet's disease treated with interferon-alpha-2a, J Rheumatol, vol.35, issue.5, pp.896-903, 2008.

C. M. Deuter, I. Kotter, and I. Gunaydin, Ocular involvement in Behcet's disease: first 5-year-results for visual development after treatment with interferon alfa-2a

, Ophthalmologe, vol.101, issue.2, pp.129-134, 2004.

E. Alpsoy, C. Durusoy, and E. Yilmaz, Interferon alfa-2a in the treatment of Behcet disease: a randomized placebo-controlled and double-blind study, Arch Dermatol, vol.138, issue.4, pp.467-471, 2002.

C. C. Zouboulis and C. E. Orfanos, Treatment of Adamantiades-Behcet disease with systemic interferon alfa, Arch Dermatol, vol.134, issue.8, pp.1010-1016, 1998.

S. Onal, H. Kazokoglu, and A. Koc, Long-term efficacy and safety of low-dose and dose-escalating interferon alfa-2a therapy in refractory Behcet uveitis, Arch Ophthalmol, vol.129, issue.3, pp.288-294, 2011.

C. M. Deuter, I. Kotter, and G. R. Wallace, Behcet's disease: ocular effects and treatment, Prog Retin Eye Res, vol.27, issue.1, pp.111-136, 2008.

L. M. Pfeffer, J. G. Kim, and S. R. Pfeffer, Role of nuclear factor-kappaB in the antiviral action of interferon and interferonregulated gene expression, J Biol Chem, vol.279, issue.30, pp.31304-31311, 2004.

V. Hamuryudan, Y. Ozyazgan, and Y. Fresko, Interferon alfa combined with azathioprine for the uveitis of Behcet's disease: an open study, Isr Med Assoc J, vol.4, issue.11, pp.928-930, 2002.

G. Sobaci, U. Erdem, and A. H. Durukan, Safety and effectiveness of interferon alpha-2a in treatment of patients with Behcet's uveitis refractory to conventional treatments, Ophthalmology, vol.117, issue.7, pp.1430-1435, 2010.

C. M. Deuter, M. Zierhut, and A. Mohle, Long-term remission after cessation of interferon-alpha treatment in patients with severe uveitis due to Behcet's disease, Arthritis Rheum, vol.62, issue.9, pp.2796-2805, 2010.

I. Kotter, M. Zierhut, and A. K. Eckstein, Human recombinant interferon alfa-2a for the treatment of Behcet's disease with sight threatening posterior or panuveitis, Br J Ophthalmol, vol.87, issue.4, pp.423-431, 2003.

A. Arida, K. Fragiadaki, and E. Giavri, Anti-TNF agents for Behcet's disease: analysis of published data on 369 patients, Semin Arthritis Rheum, vol.41, issue.1, pp.61-70, 2011.

L. Niccoli, C. Nannini, and M. Benucci, Long-term efficacy of infliximab in refractory posterior uveitis of Behcet's disease: a 24-month follow-up study, Rheumatology (Oxford), vol.46, issue.7, pp.1161-1164, 2007.

S. Tognon, G. Graziani, and R. Marcolongo, Anti-TNF-alpha therapy in seven patients with Behcet's uveitis: advantages and controversial aspects, Ann N Y Acad Sci, vol.1110, pp.474-484, 2007.

A. Adan, V. Hernandez, and S. Ortiz, Effects of infliximab in the treatment of refractory posterior uveitis of Behcet's disease after withdrawal of infusions, Int Ophthalmol, vol.30, issue.5, pp.577-581, 2010.

A. A. Okada, H. Goto, and S. Ohno, Multicenter study of infliximab for refractory uveoretinitis in Behcet disease, Arch Ophthalmol, vol.130, issue.5, pp.592-598, 2012.

G. Levy-clarke, D. A. Jabs, R. W. Read, J. T. Rosenbaum, A. Vitale et al., Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders, Ophthalmology, vol.121, issue.3, pp.785-796, 2014.

N. Stuebiger, I. Koetter, and M. Zierhut, Complete regression of retinal neovascularization after therapy with interferon alfa in Behcet's disease, Br J Ophthalmol, vol.84, issue.12, pp.1437-1438, 2000.

K. F. Tabbara and A. I. Al-hemidan, Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behcet disease, Am J Ophthalmol, vol.146, issue.6, pp.845-850, 2008.

S. Pay, I. Simsek, and H. Erdem, Immunopathogenesis of Behcet's disease with special emphasize on the possible role of antigen presenting cells, Rheumatol Int, vol.27, issue.5, pp.417-424, 2007.

C. Mendoza-pinto, M. Garcia-carrasco, and M. Jimenez-hernandez, Etiopathogenesis of Behcet's disease, Autoimmun Rev, vol.9, issue.4, pp.241-245, 2010.

P. De-chambrun, M. Wechsler, B. Geri, and G. , New insights into the pathogenesis of Behcet's disease, Autoimmun Rev, vol.11, issue.10, pp.687-698, 2012.

A. Mahr and C. Maldini, Rev Med Interne, vol.35, issue.2, pp.81-89, 2014.

J. Plskova, K. Greiner, and J. V. Forrester, Interferon-alpha as an effective treatment for noninfectious posterior uveitis and panuveitis, Am J Ophthalmol, vol.144, issue.1, pp.55-61, 2007.

A. Raza, S. Mittal, and G. K. Sood, Interferon-associated retinopathy during the treatment of chronic hepatitis C: a systematic review, J Viral Hepat, vol.20, issue.9, pp.593-599, 2013.

Y. Allanore, J. Sellam, and F. Batteux, Induction of autoantibodies in refractory rheumatoid arthritis treated by infliximab, Clin Exp Rheumatol, vol.22, issue.6, pp.756-758, 2004.

E. B. Suhler, J. R. Smith, and M. S. Wertheim, A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes, Arch Ophthalmol, vol.123, issue.7, pp.903-912, 2005.